Cardiovascular Consequences of Sleep-Disordered Breathing: Past, Present and Future. Report of a Workshop from the National Center on Sleep Disorders Research and the National Heart, Lung, and Blood Institute

Circulation

Volumn 109, Issue 8, 2004, Pages 951-957

  Quan, Stuart F ^a,c   Gersh, Bernard J ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; HEART ARRHYTHMIA; HEART FAILURE; HEREDITY; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP DISORDERED BREATHING; THROMBOSIS;

ADULT; ARRHYTHMIA; CARDIOVASCULAR DISEASES; CHILD; COMORBIDITY; CORONARY ARTERIOSCLEROSIS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; EPIDEMIOLOGIC STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; MALE; OBESITY; RISK FACTORS; SLEEP APNEA SYNDROMES; SLEEP APNEA, OBSTRUCTIVE; THROMBOPHILIA;

EID: 1442286779     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000118216.84358.22     Document Type: Conference Paper

References (46)

1. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230-1235.
2. Partinen M. Epidemiology of obstructive sleep apnea syndrome. Curr Opin Pulm Med. 1995;1:482-487.
3. Newman AB, Nieto FJ, Guidry U, et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol. 2001;154:50-59.
4. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension [see comments]. N Engl J Med. 2000;342:1378-1384.
5. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA. 2000;283:1829-1836.
6. Hu FB, Willett WC, Manson JE, et al. Snoring and risk of cardiovascular disease in women. J Am Coll Cardiol. 2000;35:308-313.
7. Brooks D, Horner RL, Kozar LF, et al. Obstructive sleep apnea as a cause of systemic hypertension: evidence from a canine model. J Clin Invest. 1997;99:106-109.
8. Somers VK, Dyken ME, Clary MP, et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96:1897-1904.
9. Davies CW, Crosby JH, Mullins RL, et al. Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax. 2000;55:736-740.
10. Logan AG, Perlikowski SM, Mente A, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens. 2001;19:2271-2277.
11. Hla KM, Skatrud JB, Finn L, et al. The effect of correction of sleep-disordered breathing on BP in untreated hypertension. Chest. 2002;122:1125-1132.
12. Ziegler MG, Mills PJ, Loredo JS, et al. Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea. Chest. 2001;120:887-893.
13. Phillips BG, Narkiewicz K, Pesek CA, et al. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens. 1999;17:61-66.
14. Vgontzas AN, Chrousos GP. Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders. Endocrinol Metab Clin North Am. 2002;31:15-36.
15. Shamsuzzaman A, Winnick M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation. 2002;105:2462-2464.
16. Arnulf I, Merino-Andreu M, Perrier A, et al. Obstructive sleep apnea and venous thromboembolism. JAMA. 2002;287:2655-2656.
17. Bokinsky G, Miller M, Ault K, et al. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure: a preliminary investigation. Chest. 1995;108:625-630.
18. Chin K, Ohi M. New insights into the therapy and pathophysiology of patients with obstructive sleep apnoea syndrome. Respirology. 1998;3:139-143.
19. von Kanel R, Le DT, Nelesen RA, et al. The hypercoagulable state in sleep apnea is related to comorbid hypertension. J Hypertens. 2001;19:1445-1451.
20. Schulz R, Mahmoudi S, Hattar K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med. 2000;162:566-570.
21. Tanus-Santos JE, Desai M, et al. Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol. Pharmacogenetics. 2002;12:407-413.
22. Hung J, Whitford EG, Parsons RW, et al. Association of sleep apnoea with myocardial infarction in men. Lancet. 1990;336:261-264.
23. Leung RST, Bradley TD. Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med. 2001;164:2147-2165.
24. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study [see comments]. Am J Respir Crit Care Med. 2001;163:19-25.
25. Punjabi NM, Sorkin JD, Katzel LI, et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med. 2002;165:677-682.
26. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354:1435-1439.
27. Mander BA, Colecchia E, Spiegel K, et al. Short sleep: a risk factor for insulin resistance and obesity. Sleep. 2001;24:A74-A75.
28. Phillips BG, Kato M, Narkiewicz K, et al. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol. 2000;279:H234-H237.
29. Manzella D, Parillo M, Razzino T, et al. Soluble leptin receptor and insulin resistance as determinant of sleep apnea. Int J Obes Relat Metab Disord. 2002;26:370-375.
30. Schulz R, Mahmoudi S, Hattar K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med. 2000;162:566-570.
31. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-1143.
32. Phillips BG, Somers VK. Sleep disordered breathing and risk factors for cardiovascular disease. Curr Opin Pulm Med. 2002;8:516-520.
33. Redfield MM, Jacobsen SJ, Burnett JC Jr, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003;289:194-202.
34. Sin DD, Fitzgerald F, Parker JD, et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med. 1999;160:1101-1106.
35. Lanfranchi PA, Somers VK, Braghiroli A, et al. Central sleep apnea in left ventricular dysfunction: prevalence and implications for arrhythmic risk. Circulation. 2003;107:727-732.
36. Naughton MT, Bradley TD. Sleep apnea in congestive heart failure. Clin Chest Med. 1998;19:99-113.
37. Parker JD, Brooks D, Kozar LF, et al. Acute and chronic effects of airway obstruction on canine left ventricular performance. Am J Respir Crit Care Med. 1999;160:1888-1896.
38. Kaneko Y, Floras JS, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med. 2003;348:1233-1241.
39. Sin DD, Logan AG, Fitzgerald FS, et al. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation. 2000;102:61-66.
40. Flemons WW, Remmers JE, Gillis AM. Sleep apnea and cardiac arrhythmias: is there a relationship? Am Rev Respir Dis. 1993;148:618-621.
41. Shepard JW, Garrison MW, Grither DA, et al. Relationship of ventricular ectopy to oxyhemoglobin desaturation in patients with obstructive sleep apnea. Chest. 1985;88:335-340.
42. Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol. 1983;52:490-494.
43. Kanagala R, Murali NS, Friedman PA, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003;107:2589-2594.
44. Harbison J, O'Reilly P, McNicholas WT. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest. 2000;118:591-595.
45. Veale D, Chailleux E, Hoorelbeke-Ramon A, et al. Mortality of sleep apnoea patients treated by nasal continuous positive airway pressure registered in the ANTAVIR Observatory. Association Nationale pour le Traitement A Domicile de l'Insuffisance Respiratoire Chronique. Eur Respir J. 2000;15:326-331.
46. Strohl KP. Diabetes and sleep apnea. Sleep. 1996;19(suppl):S225-S228.